Menu
Back to Journals » Risk Management and Healthcare Policy » Volume 11
Commentary
Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 77,813 | Dovepress* | 14,824+ | 1,683 | 16,507 | |
| PubMed Central* | 62,989 | 1,562 | 64,551 | ||
| Totals | 77,813 | 3,245 | 81,058 | ||
| *Since 17 August 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 38 | 0 | 0 | 0 | 12 | 26 |
View citations on PubMed Central and Google Scholar